As a distributed infrastructure, ELIXIR has a mixed funding model with contributions coming from a number of mostly public sources:
- Collectively, the ELIXIR Hub and Nodes compete for grant funding from the European Union, under Horizon 2020 and the Innovative Medicine Initiative (IMI);
- The ELIXIR Hub is funded through membership fees paid by Member countries, and much of this funding is then transferred back to Nodes (e.g. via Implementation Studies) to deliver ELIXIR’s five-year Scientific Programme;
- ELIXIR Nodes are typically funded through national-level investments, supporting national coordination, and the development and operation of services;
- ELIXIR Nodes also receive support from international funders, such as the US’ National Institute of Health (NIH);
- Finally, some ELIXIR Nodes are able to access European Union Structural Funds, for instance to support national coordination and the purchasing of facilities.
Other sources of funding for Nodes include foundations (e.g. the Wellcome Trust and Wallenberg Foundation), and also the industry, though the latter is modest compared to the public funding received by Nodes.
ELIXIR’s Long-term sustainability plan provides an overview of previous, current and future actions that aim to support the sustainability of bioinformatics resources across ELIXIR’s Nodes. These actions are articulated around four main objectives:
- Identify the scale of the funding challenge;
- Promote the development of fit for purpose funding models for sustaining open and free bioinformatics resources;
- Use excellence and quality of ELIXIR’s bioinformatics resources as drivers of sustainability;
- Demonstrate and communicate the impact of ELIXIR and its bioinformatics resources.
This Plan addresses many of the recommendations from:
- the European Commission Staff Working Document on the long-term sustainability of research infrastructures.
- the Long-Term Sustainability Working Group of the European Strategy Forum for Research Infrastructures (ESFRI).